Evidence map›Paper›PMID 38254700›Full record

ReviewBiomolecules2024

The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for

Eizo Takashima, Hitoshi Otsuki, Masayuki Morita, Daisuke Ito, Hikaru Nagaoka, Takaaki Yuguchi, Ifra Hassan, Takafumi Tsuboi

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Eizo TakashimaDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.ORCID 0000-0001-9070-8499
Hitoshi OtsukiDivision of Medical Zoology, Department of Microbiology and Immunology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan.
Masayuki MoritaDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
Daisuke ItoDivision of Medical Zoology, Department of Microbiology and Immunology, Faculty of Medicine, Tottori University, Yonago 683-8503, Japan.ORCID 0000-0003-4554-6085
Hikaru NagaokaDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
Takaaki YuguchiDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
Ifra HassanDivision of Malaria Research, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.
Takafumi TsuboiDivision of Cell-Free Sciences, Proteo-Science Center, Ehime University, Matsuyama 790-8577, Japan.ORCID 0000-0002-7415-1325
Ehime University · JPTottori University · JPCellFree Sciences (Japan) · JP

Funding

Japan Society for the Promotion of Science JP20H03481, JP21H02724, JP21KK0138
6 · The paper itself

Abstract

Extensive control efforts have significantly reduced malaria cases and deaths over the past two decades, but in recent years, coupled with the COVID-19 pandemic, success has stalled. The WHO has urged the implementation of a number of interventions, including vaccines. The modestly effective RTS,S/AS01 pre-erythrocytic vaccine has been recommended by the WHO for use in sub-Saharan Africa against

Indexed as

MalariaMalaria VaccinesChildErythrocytesHumansPandemicsPlasmodium falciparumMalaria Vaccinesantigen discoveryasexual blood stagemalariaPlasmodium falciparumvaccine

Identifiers

PMID38254700
PMCPMC10813614
OpenAlexW4390824356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.